← Leaderboards
Craig A Elmets
University Of Alabama At Birmingham
$8,601,504
Attributed
$8,601,504
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$21,355,036 · 18
VA$0 · 2
By mechanism
P01$9,825,449 · 4
P30$6,303,541 · 6
R01$3,946,372 · 3
T32$861,299 · 1
R21$408,375 · 1
N01$10,000 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Donald D Muccio$2,766,715
- John Michael Ruppert$5,190,544
- Matthew B Renfrow$7,936,462
- Stephanie Nicole Brosius$33,141
- Melissa L Harris$1,429,158
Others in their field
Top investigators on “Prevention”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventionSkin CarcinomaMalignant NeoplasmsChemopreventive AgentPreventResearch PersonnelClinical TrialsSkin Cancer PreventionAnimal ModelBiological MarkersChemopreventionCancer ChemopreventionCutaneousEvaluationProgramsRetinoidsInterestSkinBaseDesignSquamous Cell CarcinomaBasal Cell CarcinomaUniversitiesOral
Grant awards (79)
UV Photodamage to the Skin: Prevention by Mutant p53 Immunization$185,625
R21 · FY2023 · ES · contact PI
Topical Chemoprevention of Skin Cancer Biomarkers$229,846
R01 · FY2022 · CA · contact PI
UV Photodamage to the Skin: Prevention by Mutant p53 Immunization$222,750
R21 · FY2022 · ES · contact PI
RXR Rexinoids for Cancer Chemoprevention$900,436
P01 · FY2021 · CA · contact PI
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients$215,277
P01 · FY2021 · CA · contact PI
Topical Chemoprevention of Skin Cancer Biomarkers$101,726
R01 · FY2021 · CA · contact PI
Core 1: Administrative Core$75,501
P01 · FY2021 · CA · contact PI
RXR Rexinoids for Cancer Chemoprevention$59,920
P01 · FY2021 · CA · contact PI
Program Integration and Management$6,221
P01 · FY2021 · CA · contact PI
RXR Rexinoids for Cancer Chemoprevention$1,516,989
P01 · FY2020 · CA · contact PI
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients$375,966
P01 · FY2020 · CA · contact PI
05 Cancer Chemoprevention Program$121,913
P30 · FY2020 · CA · contact PI
Core 1: Administrative Core$114,230
P01 · FY2020 · CA · contact PI
RXR Rexinoids for Cancer Chemoprevention$1,426,503
P01 · FY2019 · CA · contact PI
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients$371,600
P01 · FY2019 · CA · contact PI
Topical Chemoprevention of Skin Cancer Biomarkers$326,174
R01 · FY2019 · CA · contact PI
05 Cancer Chemoprevention Program$118,946
P30 · FY2019 · CA · contact PI
Core 1: Administrative Core$109,864
P01 · FY2019 · CA · contact PI
RXR Rexinoids for Cancer Chemoprevention$60,295
P01 · FY2019 · CA · contact PI
RXR Rexinoids for Cancer Chemoprevention$59,920
P01 · FY2019 · CA · contact PI
05 Cancer Chemoprevention Program$8,695
P30 · FY2019 · CA · contact PI
Host Defense Mechanisms in Melanoma Pathogenesis$0
I01 · FY2019 · VA · contact PI
RXR Rexinoids for Cancer Chemoprevention$1,481,363
P01 · FY2018 · CA · contact PI
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients$378,978
P01 · FY2018 · CA · contact PI
Topical Chemoprevention of Skin Cancer Biomarkers$336,263
R01 · FY2018 · CA · contact PI
Core 1: Administrative Core$117,242
P01 · FY2018 · CA · contact PI
05 Cancer Chemoprevention Program$99,610
P30 · FY2018 · CA · contact PI
05 Cancer Chemoprevention Program$8,649
P30 · FY2018 · CA · contact PI
05 Cancer Chemoprevention Program$3,965
P30 · FY2018 · CA · contact PI
Program Integration and Management$2,278
P01 · FY2018 · CA · contact PI
05 Cancer Chemoprevention Program$2,264
P30 · FY2018 · CA · contact PI
05 Cancer Chemoprevention Program$1,978
P30 · FY2018 · CA · contact PI
Host Defense Mechanisms in Melanoma Pathogenesis$0
I01 · FY2018 · VA · contact PI
RXR Rexinoids for Cancer Chemoprevention$1,770,718
P01 · FY2017 · CA · contact PI
Project 1: Evaluation of UAB30 on skin cancer biomarkers in human renal transplant recipients$660,371
P01 · FY2017 · CA · contact PI
Topical Chemoprevention of Skin Cancer Biomarkers$336,263
R01 · FY2017 · CA · contact PI
Core 1: Administrative Core$119,499
P01 · FY2017 · CA · contact PI
05 Cancer Chemoprevention Program$111,104
P30 · FY2017 · CA · contact PI
Program Integration and Management$2,278
P01 · FY2017 · CA · contact PI
Host Defense Mechanisms in Melanoma Pathogenesis$0
I01 · FY2017 · VA · contact PI
Topical Chemoprevention of Skin Cancer Biomarkers$336,263
R01 · FY2016 · CA · contact PI
05 Cancer Chemoprevention Program$33,308
P30 · FY2016 · CA · contact PI
05 Cancer Chemoprevention Program$8,694
P30 · FY2016 · CA · contact PI
Host Defense Mechanisms in Melanoma Pathogenesis$0
I01 · FY2016 · VA · contact PI
Host Defense Mechanisms in Polyaromatic Hydrogen Carcinogenesis$0
I01 · FY2014 · VA · contact PI
UAB Skin Diseases Research Center$485,498
P30 · FY2013 · AR · contact PI
Host Defense Mechanisms in Polyaromatic Hydrogen Carcinogenesis$0
I01 · FY2013 · VA · contact PI
UAB Skin Diseases Research Center$524,536
P30 · FY2012 · AR · contact PI
Host Defense Mechanisms in Polyaromatic Hydrogen Carcinogenesis$0
I01 · FY2012 · VA · contact PI
UAB Skin Diseases Research Center$531,367
P30 · FY2011 · AR · contact PI
Host Defense Mechanisms in Polyaromatic Hydrogen Carcinogenesis$0
I01 · FY2011 · VA · contact PI
UAB Skin Diseases Research Center$529,517
P30 · FY2010 · AR · contact PI
Training in Investigative Dermatology$218,538
T32 · FY2010 · AR · contact PI
UAB Skin Diseases Research Center$526,988
P30 · FY2009 · AR · contact PI
Training in Investigative Dermatology$146,954
T32 · FY2009 · AR · contact PI
Core Center$570,585
P30 · FY2008 · AR · contact PI
Training in Investigative Dermatology$172,658
T32 · FY2008 · AR · contact PI
Administrative Core$113,165
P30 · FY2008 · AR · contact PI
Natural History of Dermal Neurofibromas In Patients with Neurofibromatosis 1$45,218
P30 · FY2008 · AR · contact PI
Core Center$572,305
P30 · FY2007 · AR · contact PI
Training in Investigative Dermatology$208,889
T32 · FY2007 · AR · contact PI
Administrative Core$113,340
P30 · FY2007 · AR · contact PI
Natural History and Biology of Dermal Neurofibromas in Patients with Neuro...$35,304
P30 · FY2007 · AR · contact PI
Core Center$585,090
P30 · FY2006 · AR · contact PI
Training in Investigative Dermatology$114,260
T32 · FY2006 · AR · contact PI
NO.78 PHASE IIB CLINICAL TRIAL OF A TOPICAL AGENT TO PREVENT NON-MELAN-261015136$0
N01 · FY2006 · CN · contact PI
A PHASE II CLINICAL TRIAL OF CELECOXIB (OR NSAID) IN SUBJECTS WITH ACT-261085183$0
N01 · FY2006 · CA · contact PI
Core Center$579,562
P30 · FY2005 · AR
Core Center$571,940
P30 · FY2004 · AR
PHTHALOCYANINE PDT--IN VIVO RESPONSES AND MECHANISMS$290,588
R01 · FY2004 · CA
PHTHALOCYANINE PDT--IN VIVO RESPONSES AND MECHANISMS$290,588
R01 · FY2003 · CA
IMMUNODERMATOLOGICAL THERAPY OF SKIN CANCER$212,908
R01 · FY2003 · CA
PHTHALOCYANINE PDT--IN VIVO RESPONSES AND MECHANISMS$290,588
R01 · FY2002 · CA
IMMUNODERMATOLOGICAL THERAPY OF SKIN CANCER$209,371
R01 · FY2002 · CA
PHTHALOCYANINE PDT--IN VIVO RESPONSES AND MECHANISMS$290,588
R01 · FY2001 · CA
IMMUNODERMATOLOGICAL THERAPY OF SKIN CANCER$205,934
R01 · FY2001 · CA
PHTHALOCYANINE PDT--IN VIVO RESPONSES AND MECHANISMS$286,673
R01 · FY2000 · CA
IMMUNODERMATOLOGICAL THERAPY OF SKIN CANCER$202,599
R01 · FY2000 · CA
PHASE II CLINICAL TRIAL OF CELECOXIB (OR NSAID) IN SUB$10,000
N01 · FY2000 · CN